SUNITINIB IN ADVANCED CLEAR CELL RENAL CANCER: A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Bruni, G. S. [1 ]
Facchini, G. [1 ]
Iaffaioli, V. R. [1 ]
Pisano, C. [1 ]
Pignata, S. [1 ]
机构：
[1] Natl Canc Inst Naples, Urogynecol Dept, Naples, Italy
来源：
EJC SUPPLEMENTS | 2008年 / 6卷 / 14期
关键词：
D O I：
10.1016/j.ejcsup.2008.06.046
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：123 / 123
页数：1
相关论文
共 50 条
  • [41] Sunitinib-related macrocytosis in patients with advanced renal cell cancer (RCC)
    Price, J. A.
    Shaarbaf, R.
    Wood, L. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [42] The Outcome of Patients Treated with Sunitinib Prior to Planned Nephrectomy in Metastatic Clear Cell Renal Cancer
    Powles, Thomas
    Blank, Christian
    Chowdhury, Simon
    Horenblas, Simon
    Peters, John
    Shamash, Jonathan
    Sarwar, Naveed
    Boleti, Ekaterini
    Sahdev, Anju
    O'Brien, Tim
    Berney, Dan
    Beltran, Luis
    Nathan, Paul
    Haanen, John
    Bex, Axel
    EUROPEAN UROLOGY, 2011, 60 (03) : 448 - 454
  • [43] Sorafenib in advanced renal cell cancer: Final results from a single institution experience
    Procopio, Giuseppe
    Verzoni, Elena
    Bajetta, Roberto
    Mancin, Maddalena
    Pusceddu, Sara
    Catena, Laura
    De Dosso, Sara
    Gevorgyan, Arpine
    Zilembo, Nicoletta
    Bajetta, Emilio
    ANNALS OF ONCOLOGY, 2007, 18 : 81 - 81
  • [44] THE OUTCOME OF PATIENTS TREATED WITH UPFRONT SUNITINIB PRIOR TO NEPHRECTOMY IN METASTATIC CLEAR CELL RENAL CANCER
    Powles, T.
    Blank, C.
    Chowdhury, S.
    Peters, J.
    Haanen, J.
    O'Brien, T.
    Rockall, A. R.
    Sahdev, A. S.
    Nichol, D.
    Boleti, K.
    Irfan, I.
    Horenblas, S.
    Bex, A.
    EUROPEAN UROLOGY SUPPLEMENTS, 2011, 10 (02) : 102 - 103
  • [45] Comparing Everolimus to Sunitinib in Non-clear-cell Renal Cell Carcinoma
    Bex, Axel
    Ljungberg, Borje
    EUROPEAN UROLOGY, 2016, 69 (05) : 875 - 876
  • [46] Sunitinib versus everolimus for non-clear-cell renal cell carcinoma
    Rebecca Kelsey
    Nature Reviews Urology, 2016, 13 (3) : 124 - 124
  • [47] Treatment with male sunitinib with clear cell renal cell carcinoma and metabolic syndrome
    Czastkiewicz-Trawinska, Diana
    Kaiser, Andrzej
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : A13 - A14
  • [48] RCAN1.4 acts as a suppressor of cancer progression and sunitinib resistance in clear cell renal cell carcinoma
    Song, Zhengshuai
    Cao, Qi
    Ruan, Hailong
    Yang, Hongmei
    Wang, Keshan
    Bao, Lin
    Cheng, Gong
    Xu, Tianbo
    Xiao, Haibing
    Wang, Cheng
    Liu, Di
    Chen, Ke
    Zhang, Xiaoping
    EXPERIMENTAL CELL RESEARCH, 2018, 372 (02) : 118 - 128
  • [49] Postoperative care in advanced vulvar cancer - retrospective single centre experience
    Kovac, Luka
    Kostoski, Saso
    Cvjeticanin, Branko
    Smrkolj, Spela
    Barbic, Matija
    Jansa, Vid
    Lasic, Mateja
    Pirs, Bostjan
    Pirs, Tina Kunic
    Stefanovska, Marina Jakimovska
    Staric, Kristina Drusany
    Meglic, Leon
    Kobal, Borut
    Kenda Suster, Natasa
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024, 34 (SUPPL_1) : A546 - A546
  • [50] Molecular profile of sunitinib resistance in clear-cell renal cell carcinoma
    Torras, Oscar Reig
    Marin-Aguilera, Mercedes
    Jimenez, Natalia
    Laia, Pare
    Galvan, Patricia
    Mallofre, Carme
    Prat, Aleix
    Mellado, Begona
    CANCER RESEARCH, 2017, 77
12345